feed,title,long_url,short_url
Benzinga,FDA Approves PolarityTE's Phase 3 Study Of SkinTE In Chronic Cutaneous Ulcer,https://benzinga.com/general/biotech/22/01/25092490/fda-approves-polaritytes-phase-3-study-of-skinte-in-chronic-cutaneous-ulcer,https://j.mp/3IaWJqY
Benzinga,"FDA Grants Fast Track Tags To Drug Candidates For Antares Pharma, Celcuity, Celularity",https://benzinga.com/general/biotech/22/01/25091584/fda-grants-fast-track-tags-to-drug-candidates-for-antares-pharma-celcuity-celularity,https://j.mp/3tDv2mX
Benzinga,12 Health Care Stocks Moving In Tuesday's Intraday Session,https://benzinga.com/intraday-update/22/01/25093521/12-health-care-stocks-moving-in-tuesdays-intraday-session,https://j.mp/3nB8iA8
Benzinga,12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session,https://benzinga.com/intraday-update/22/01/25093525/12-consumer-discretionary-stocks-moving-in-tuesdays-intraday-session,https://j.mp/3rMZmJl
Benzinga,10 Information Technology Stocks Moving In Tuesday's Intraday Session,https://benzinga.com/intraday-update/22/01/25093531/10-information-technology-stocks-moving-in-tuesdays-intraday-session,https://j.mp/3GBdIm2
Benzinga,10 Communication Services Stocks Moving In Tuesday's Intraday Session,https://benzinga.com/intraday-update/22/01/25093533/10-communication-services-stocks-moving-in-tuesdays-intraday-session,https://j.mp/3qG7oV2
